CoChat

Early thyroxine treatment in Down syndrome and thyroid function later in life

Open access
Zwaveling-Soonawala, Nitash, Witteveen, M Emma, Marchal, Jan Pieter, Klouwer, Femke C C, Ikelaar, Nadine A, Smets, Anne M J B, van Rijn, Rick R, Endert, Erik, Fliers, Eric, van Trotsenburg, A S Paul · 2017 · European Journal of Endocrinology

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Objective: The hypothalamus–pituitary–thyroid (HPT) axis set point develops during the fetal period and first two years of life. We hypothesized that thyroxine treatment during these first two years, in the context of a randomized controlled trial (RCT) in children with Down syndrome, may have influenced the HPT axis set point and may also have influenced the development of Down syndrome-associated autoimmune thyroiditis. Methods: We included 123 children with Down syndrome 8.7 years after the end of an RCT comparing thyroxine treatment vs placebo and performed thyroid function tests and thyroid ultrasound. We analyzed TSH and FT4 concentrations in the subgroup of 71 children who were currently not on thyroid medication and had no evidence of autoimmune thyroiditis. Results: TSH concentrations did not differ, but FT4 was significantly higher in the thyroxine-treated group than that in the placebo group (14.1 vs 13.0 pmol/L; P = 0.02). There was an increase in anti-TPO positivity, from 1% at age 12 months to 6% at age 24 months and 25% at age 10.7 years with a greater percentage of children with anti-TPO positivity in the placebo group (32%) compared with the thyroxine-treated group (18.5%) (P = 0.12). Thyroid volume at age 10.7 years (mean: 3.4 mL; range: 0.5–7.5 mL) was significantly lower (P < 0.01) compared with reference values (5.5 mL; range: 3–9 mL) and was similar in the thyroxine and placebo group. Conclusion: Thyroxine treatment during the first two years of life led to a mild increase in FT4 almost 9 years later on and may point to an interesting new mechanism influencing the maturing HPT axis set point. Furthermore, there was a trend toward less development of thyroid autoimmunity in the thyroxine treatment group, suggesting a protective effect of the early thyroxine treatment. Lastly, thyroid volume was low possibly reflecting Down-specific thyroid hypoplasia.

Overview

Integrity signals

Registry

Crossref · 10.1530/eje-16-0858

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Cited by

See all 24

Metadata

Authors
Zwaveling-Soonawala, N., Witteveen, M. E., Marchal, J. P., Klouwer, F. C. C., Ikelaar, N. A., Smets, A. M. J. B., van Rijn, R. R., Endert, E., Fliers, E., & van Trotsenburg, A. S. P.
Affiliations
  • Emma Kinderziekenhuis (NL)
  • Amsterdam UMC Location University of Amsterdam (NL)
Venue
European Journal of Endocrinology
Published
2017-05
Volume
176
Issue
5
Pages
505-513
ISSN
  • 0804-4643 (ISSN-L)
  • 1479-683X
OpenAlex
W2582317675
Cited by
23
References
29
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 1
FWCI
1.94
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • European Journal of Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
Keywords
Down syndrome, thyroxine therapy, hypothalamic-pituitary-thyroid axis, autoimmune thyroiditis, thyroid peroxidase antibodies, thyroid function, free thyroxine, thyroid volume, thyroid hypoplasia
MeSH terms
Adult, Age Factors, Child, Down Syndrome, Female, Follow-Up Studies, Humans, Male, Thyroid Function Tests, Thyroid Gland, Thyrotropin, Thyroxine, Treatment Outcome, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.